Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-048259)

Filing Details

Accession Number:: 0001209191-23-048259
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-05 21:00:08
Reporting Period:: 2023-09-01

Accepted Time:: 2023-09-05 21:00:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899460	Mannkind Corp	MNKD	Pharmaceutical Preparations (2834)	133607736

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1674282	Michael Castagna	1 Casper Street Danbury CT 06810	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.01 Par Value	Disposition	2023-09-01	10,000	$4.61	2,436,039	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2023-09-05	66,892	$4.91	2,369,147	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	J	Direct

Footnotes

Transaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022.
Reporting person transferred 66,892 shares of MNKD common stock to his ex-spouse pursuant to a divorce decree on September 5, 2023.